<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How did TVTX's Q4 earnings surprise investors?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        4/8/2025 02:19pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Travere Therapeutics (TVTX) reported an earnings per share (EPS) surprise of $0.17 for the fiscal quarter ending December 31, 2024, compared to the consensus estimate. This positive surprise indicates that the company's performance exceeded market expectations, likely due to factors such as strong revenue growth, effective cost management, or favorable market conditions for their products.

</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar,as,at,au,av,aw,ax,ay,az,aA,aB,aC,aD,aE,aF){return {layout:"default",data:[{noData:b,currentQuestion:g,textDescription:K,comeFrom:"AInvestShareLink",events:[],answerSource:n}],fetch:{},error:o,state:{sharePreviewModule:{loadJgySuccess:e,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:i,agent_id:a,output_media_info:[],task_id:a,language:a,source:n,cache_builder:a,reply_action:"Answer",execute_mode:A,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did TVTX's Q4 earnings surprise investors?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did TVTX's Q4 earnings surprise investors?\",\"user_id\":\"dp77317480\",\"user_name\":\"\",\"trace_id\":\"7dd6a43e-b38f-4c24-bbca-5719a4602bb8\",\"session_id\":\"7dd6a43e-b38f-4c24-bbca-5719a4602bb8\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"query_data",query_type:B,text:"1 results found:\n|stock code|stock name|Last Price|Last Change|EPS Surprise[20241231]|\n|---|---|---|---|---|\n|TVTX|Travere Therapeutics|$15.17|1.2%|0.17|\n",query_data:{number:i,title:C,query_type:B,condition:a,model_sql:L,data_ext_params:{merge_repeat:b,expand_index:c,data_add:i,add_index:e}}}],answer_chain_name:M,agent_mode:N,native_answer:a,come_from:a,text_answer:K,trace_id:j,cost:10365,event_names:a,question:g,fallback_type:O,input_type:P,fall_back_reason:{fall_back_type:O,risk_detail:{matched_words:[]}},session_id:j,first_return_cost:2173,cache_type:a,question_id:j,transfer_question:g,signal_type:"ON_COMPLETE",start_time:Q,remote_svc:n,slots:[],answer_type:A,user_id:u,skill_name:D},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:j,session_id:j,user_id:u,question:g,source:n,raw_question:g,version:"3.4.1",action_name:D,nlu:{entity:[{type:R,value:S,market:E}]},deep_research:b,deep_thinking:b,agent_mode:N},extra:{}},{answer_path:v,section:{id:w,info_texts:["Thinking"],show_type:x,choice:[],result_page:{},tag_info_list:[],is_last:c,status:"begin"},logs:[],extra:{is_deep_research:b,deep_thinking:b}},{answer_path:v,section:{id:w,info_texts:["Querying Stock: TVTX Earnings Surprise in Fiscal 2024 Q4"],show_type:x,choice:[],result_page:{},tag_info_list:[],is_last:c,status:"thinking"},logs:[],extra:{action:"Querying Stock",action_input:C,thought:"The user wants to know how TVTX's Q4 earnings surprised investors. I should focus on the earnings surprise data. I will use FinQuery for the data."}},{answer_path:d,section:{id:p,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:d,section:{id:p,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:v,section:{id:w,info_texts:["Generating Answer"],show_type:x,choice:[],result_page:{},tag_info_list:[],is_last:c,status:"ongoing"},logs:[],extra:{}},{answer_path:d,section:{id:l,info_texts:[],show_type:q,voice_txt:"Tr",text_answer:T,rich_text:T,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:d,section:{id:2000,info_texts:[],show_type:q,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:C,query_type:B,trace_data:a,index:i,model_sql:L,data_ext_params:{merge_repeat:b,expand_index:c,data_add:i,add_index:e},jump_type:"data_query"}],is_last:c},logs:[],extra:{}},{answer_path:d,section:{id:l,info_texts:[],show_type:q,voice_txt:". This",text_answer:U,rich_text:U,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:d,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:V,market_id:E,name:W,domain:R},pos:e,section_id:l,txt:W,jump_type:"pos_fenshi"}],is_last:c},logs:[],extra:{}},{answer_path:d,section:{id:p,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:d,section:{id:p,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:d,section:{id:p,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:d,section:{id:l,info_texts:[],show_type:q,voice_txt:"\n",text_answer:X,rich_text:X,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:d,section:{id:l,info_texts:[],show_type:Y,choice:[],result_page:{components:[{category:Z,puuid:_,request_config:[{related_name:$,source_type:F}],show_type:aa,tag:"Analyst Estimate Earnings",uuid:ab,title_config:{config:{display:b,display2:b,txt_style:e,type:ac,url:a},data:{h1:a,h2:a},show_type:ad}}],global:{interface_request_list:[],lowcode_json:{stack:b,visible:c,childLimit:ae,label:y,type:af,leaf:b,animate:[],version:ag,script:[],props:{test:a},path:ah,style:{"background-color":a,"box-shadow":ai,color:a,width:h,"min-height":aj,position:z,height:h},isMaterial:b,id:y,needTheme:b,hasEditor:b,packed:b,events:[],child:[{stack:b,visible:c,childLimit:e,label:"财报",type:ak,leaf:c,version:"0.0.1",animate:[],url:G,componentUuid:ab,script:[{name:"earnings",id:65539,content:"return {\r\n  mounted () {\r\n    window.__oversea_ainvest__ = {\r\n      ENV: \"production\"\r\n    }\r\n  }\r\n}"}],props:{title:"Earnings"},path:G,meta:{js_url:G},style:{"background-color":a,padding:"0",color:a,display:al,width:h,position:z,height:h},isMaterial:c,_id:am,id:ak,hasEditor:c,packed:b,events:[],isSetDefaultValue:c}]},lowcode_type:an,urp_static_data:[{name:$,value:{columns:[{index_name:ao,key:ao,type:f},{index_name:ap,key:ap,type:f}],dataSize:i,datas:[{code:V,market_code:E}]}},{name:"advance_custom_visual",value:{columns:[{index_name:aq,key:aq,type:f},{index_name:ar,key:ar,type:f},{index_name:as,key:as,type:f}],dataSize:i,datas:[{stock_code:S,start_date:"2024-01-01",end_date:"2024-12-31"}]}}]},page:{layout:{layout_data:"[{\"uuid\":\"gyyEarnings\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:H,uuid:_,voice_txt:a}},tag_info_list:[],is_last:b,uuid:"a9577c5a-1cde-4ab4-b951-6f746de99737"},logs:[],extra:{}},{answer_path:d,section:{id:l,info_texts:[],show_type:q,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:v,section:{id:w,info_texts:["Completed"],show_type:x,choice:[],result_page:{},tag_info_list:[],is_last:c,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:Y,choice:[{display_text:r,query_text:r,trace_info:{item_id:"d1f3099aa49d02bedfff96b6a2c5c56c",item_type:m,item_name:r,rec_info:at}},{display_text:s,query_text:s,trace_info:{item_id:"ba2d1f329307b6203ee79fef8b56ea17",item_type:m,item_name:s,rec_info:au}},{display_text:t,query_text:t,trace_info:{item_id:"cb8a9383d466c1e44eafa055fb88d273",item_type:m,item_name:t,rec_info:av}}],result_page:{components:[{show_type:aa,title_config:{show_type:ad,data:{h1:a,h2:a},config:{display:b,txt_style:e,type:ac,display2:b,url:a}},request_config:[{source_type:F,related_name:aw}],puuid:I,tag:a,category:Z,uuid:ax}],global:{urp_static_data:[{name:aw,value:{status_code:e,columns:[{type:f,index_name:ay,key:ay},{type:f,index_name:az,key:az},{type:f,index_name:aA,key:aA},{type:f,index_name:aB,key:aB},{type:f,index_name:aC,key:aC}],datas:[{send_text:r,item_type:m,rec_info:at,display_text:r,rec_reason:a},{send_text:s,item_type:m,rec_info:au,display_text:s,rec_reason:a},{send_text:t,item_type:m,rec_info:av,display_text:t,rec_reason:a}],dataSize:F,status_msg:a}}],lowcode_type:an,interface_request_list:[],lowcode_json:{stack:b,visible:c,childLimit:ae,label:y,type:af,leaf:b,animate:[],version:ag,script:[],props:[],path:ah,isTransparent:c,style:{"background-color":a,"box-shadow":ai,color:a,width:h,"min-height":aj,position:z,height:h},isMaterial:b,id:y,needTheme:b,hasEditor:b,packed:b,events:[],child:[{readmeUrl:"https:",stack:b,visible:c,customStyle:a,childLimit:e,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:c,version:"1.12.0",animate:[],url:J,componentUuid:ax,script:[{name:aD,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:c,renderType:"blue"},path:J,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:J},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:al,width:h,position:z,height:h},isMaterial:c,_id:am,id:aD,hasEditor:c,packed:b,events:[],isSetDefaultValue:c}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:H,voice_txt:a,tracking_info:{},uuid:I},order:{is_auto:b,render_for:H,chart_type:"command",puuid:I}},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1005,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{action_name:D,with_paid_index:b,no_refresh_answer:b,answer_source:{agent_id:a,agent_name:a,execute_mode:A,answer_chain_name:M},is_deep_research:b,deep_thinking:b,create_time:1744093176725},is_last:c}],questionItem:{data:{qStr:g,encodeFlag:b,imageData:o,docsData:[],quoteData:o},tplType:"question"},events:aE,agentId:a,param:{entity_info:{},add_info:{ori_question:g},event_list:aE,client_ip:a,question:g,user_id:u,user_name:a,trace_id:j,session_id:j,source:n,input_type:P}}],userId:u,userName:a,startTime:Q,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:o,endSignal:b,theme:"white",showTracePopup:b,traceListData:[],chatTraceTargetIndex:e,traceTableData:o,showMask:b}},serverRendered:c,routePath:"\u002Faime\u002Fshare\u002Ftvtxs-q4-earnings-surprise-investors-1ff89e\u002F",config:{_app:{basePath:aF,assetsPath:aF,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",false,true,"other\u002FopenAnswer",0,"STR","How did TVTX's Q4 earnings surprise investors?","auto",1,"7dd6a43e-b38f-4c24-bbca-5719a4602bb8","signal",2001,"llm_generated","ths_ainvest_lite_web",null,999,"rich_text","What is the current consensus rating for TVTX post-earnings?","What were the main drivers of TVTX's earnings surprise?","How did analysts' estimates compare to TVTX's actual Q4 results?","dp77317480","progress\u002Fsearching_for",1000,"searching_for","root","relative","agent","intusstock","TVTX Earnings Surprise in Fiscal 2024 Q4","explain news events","185",3,"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002Fearnings\u002F0.0.1\u002Fearnings@0.0.1index.js","aigc","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Travere Therapeutics (TVTX) reported an earnings per share (EPS) surprise of $0.17 for the fiscal quarter ending December 31, 2024, compared to the consensus estimate. This positive surprise indicates that the company's performance exceeded market expectations, likely due to factors such as strong revenue growth, effective cost management, or favorable market conditions for their products.\n\n","select   stock_code,   eps_surprise from   ustock_fin_forecast where   fiscal_date = date('2024y4q')   and stock_code = 'TVTX.O'","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite",1744093166360,"stock","TVTX.O","Travere Therapeutics (TVTX) reported an earnings per share (EPS) surprise of $0.17 for the fiscal quarter ending December 31, 2024, compared to the consensus estimate[^1]",". This positive surprise indicates that the company's performance exceeded market expectations, likely due to factors such as strong revenue growth, effective cost management, or favorable market conditions for their products.\n\n","TVTX","Travere Therapeutics","\n``` visual\n{\"uuid\":\"a9577c5a-1cde-4ab4-b951-6f746de99737\"}\n```","result_page","custom","39192","code_entity","lowcode","gyyEarnings","1","title1",9999,"thslc\u002Fthslc-common-container","1.0.1","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js","0px 0px 0px","100%","iwencai\u002Fearnings","block",19,"shunda","market_code","code","stock_code","end_date","start_date","2+679_496_21_554+0+0+7dd6a43e-b38f-4c24-bbca-5719a4602bb8+d1f3099aa49d02bedfff96b6a2c5c56c+llm_generated+aimeTagAnalysis+0+0.07904034107923508+1","2+679_496_21_554+0+0+7dd6a43e-b38f-4c24-bbca-5719a4602bb8+ba2d1f329307b6203ee79fef8b56ea17+llm_generated+aimeTagAnalysis+0+0.0768643319606781+2","2+679_496_21_554+0+0+7dd6a43e-b38f-4c24-bbca-5719a4602bb8+cb8a9383d466c1e44eafa055fb88d273+llm_generated+aimeTagAnalysis+0+0.0748879536986351+3","recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","iwencai\u002FrecommendList0326",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>